National Health Scan Stock Performance
| GEGR Stock | USD 0.02 0 15.00% |
National Health holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 7.46, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, National Health will likely underperform. Use National Health Scan value at risk, as well as the relationship between the skewness and day typical price , to analyze future returns on National Health Scan.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in National Health Scan are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, National Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
National |
National Health Relative Risk vs. Return Landscape
If you would invest 1.70 in National Health Scan on September 1, 2024 and sell it today you would earn a total of 0.60 from holding National Health Scan or generate 35.29% return on investment over 90 days. National Health Scan is currently generating 3.1987% in daily expected returns and assumes 26.3951% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than National, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
National Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as National Health Scan, and traders can use it to determine the average amount a National Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1212
| Best Portfolio | Best Equity | |||
| Good Returns | GEGR | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 26.4 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.2 actual daily | 63 63% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average National Health is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Health by adding it to a well-diversified portfolio.
National Health Fundamentals Growth
National Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of National Health, and National Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Pink Sheet performance.
| Cash Flow From Operations | (19.16 K) | |||
| Total Asset | 455 | |||
| Retained Earnings | (8.35 M) | |||
| Current Liabilities | 36 K | |||
About National Health Performance
Assessing National Health's fundamental ratios provides investors with valuable insights into National Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the National Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
iWeb Corporation operates as a medical or healthcare industry business incubator. Among the businesses it has nurtured are Radiology.com, an Internet-based radiology services and systems company, and WebMRI.com, an MRI systems design and OEM company. iWeb Corporation was founded in 1995 and is based in Los Angeles, California. GAENSEL ENERGY operates under Conglomerates classification in the United States and is traded on OTC Exchange.Things to note about National Health Scan performance evaluation
Checking the ongoing alerts about National Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for National Health Scan help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| National Health Scan is way too risky over 90 days horizon | |
| National Health Scan has some characteristics of a very speculative penny stock | |
| National Health Scan appears to be risky and price may revert if volatility continues | |
| National Health Scan has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (661.31 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| National Health generates negative cash flow from operations |
- Analyzing National Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Health's stock is overvalued or undervalued compared to its peers.
- Examining National Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National Health's pink sheet. These opinions can provide insight into National Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for National Pink Sheet Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.